In addition, studies reveal that hepatic FoxO1 plays a role in T2D since liver-specific FoxO1 activation in transgenic mice increases glucose levels and impairs glucose tolerance (65). This evidence concerns the gene FOXO1 and type 2 diabetes mellitus.